WOON GO: Open Payments
NPI 1053177436 · DULLES, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $205 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $212 |
| ABBVIE INC. | 6 | $158 |
| Novo Nordisk Inc | 5 | $107 |
| Astellas Pharma US Inc | 2 | $59 |
| Lilly USA, LLC | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Corium, LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Kerendia, UBRELVY, Ozempic, QULIPTA, Veozah, MOUNJARO, ZORYVE, Wegovy.
Industry payments across VA — which companies pay providers there.
